SCA Pharmaceuticals, LLC is recalling 922 syringes of Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection (10 mg/mL concentration) because the product may not be sterile. This prescription medication is used for intravenous (IV) or intramuscular (IM) injection and was distributed nationwide in the United States. If a medication that is intended to be sterile is contaminated, it can cause serious, life-threatening infections in patients. Consumers should immediately stop using the affected syringes and contact their healthcare provider or pharmacist for further guidance.
The lack of sterility assurance means the injection could be contaminated with microorganisms. Injecting a non-sterile drug into a patient's body can lead to severe systemic infections, sepsis, and other life-threatening medical complications.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.